Waypoint Capital Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $260K | Buy |
8,980
+468
| +5% | +$13.5K | 0.06% | 114 |
|
2024
Q2 | $238K | Buy |
8,512
+759
| +10% | +$21.2K | 0.06% | 114 |
|
2024
Q1 | $215K | Buy |
7,753
+407
| +6% | +$11.3K | 0.06% | 112 |
|
2023
Q4 | $211K | Sell |
7,346
-425
| -5% | -$12.2K | 0.06% | 113 |
|
2023
Q3 | $258K | Sell |
7,771
-186
| -2% | -$6.17K | 0.09% | 102 |
|
2023
Q2 | $292K | Buy |
7,957
+186
| +2% | +$6.82K | 0.09% | 117 |
|
2023
Q1 | $317K | Hold |
7,771
| – | – | 0.1% | 112 |
|
2022
Q4 | $398K | Sell |
7,771
-168
| -2% | -$8.61K | 0.14% | 96 |
|
2022
Q3 | $348K | Buy |
7,939
+4
| +0.1% | +$175 | 0.15% | 83 |
|
2022
Q2 | $416K | Sell |
7,935
-433
| -5% | -$22.7K | 0.19% | 72 |
|
2022
Q1 | $433K | Sell |
8,368
-440
| -5% | -$22.8K | 0.25% | 74 |
|
2021
Q4 | $520K | Buy |
+8,808
| New | +$520K | 0.36% | 56 |
|